Seattle Genetics, Inc. (Nasdaq: SGEN) has expanded its antibody-drug conjugate (ADC) collaboration with Abbott (NYSE: ABT). Under the expanded deal ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE